Embed Size (px)
Citation preview
Cancer Science 2017conferenceseries.com
cancerscience.conferenceseries.com
***For available speaker slots***[email protected]
Tentative Program
InteractiveSessions
KeynoteLectures
Exhibitors B2BMeetings
PlenaryLectures Workshops
Lisbon, Portugal July 17-19, 2017
19th Euro Congress on
Cancer Science and Therapy
Exhibitor
Cancer Science 2017conferenceseries.com
cancerscience.conferenceseries.com
Tentative Scientific ProgramKEYNOTE FORUM
Title : The Natural History of Breast CancersAlvaro Macieira-Coelho
French National Institute of Health (INSERM), FranceTitle : Breast Cancer and Personalized Medicine: Advances, Conundrums and Novel Therapeutic
InterventionsSherry A. Bradford
AccuTheranostics, Inc. , USATitle : Antitumoral Hormonal Therpay : Effects on the Uterus
Liane Deligdisch Mount Sinai School of Medicine, USA
***5 Keynote Speaker Slots Available ******Speaker Presentations***
Title : CpG Simulated Karyotypic Analysis of Chronic Lymphocytic Leukemia (CLL) Is a Significant Prognostic Factor and Should Be Performed on all PatientsNyla HeeremaThe Ohio State University Wexner Medical Center, USATitle : Evolution of a “System” for Surgical Treatment of AdenocarcinomasCharles HitchcockThe Ohio State University, USATitle : Creating the best clinical and economic evidence to assist decision-making in urological cancersAlice DragomirMcGill University ,Canada
***Workshop*** Dr. Lloyd Jenkins, Budwig Center, Spain
Title : ARF proteins as new molecular targets for the treatment of invasive breast cancerAudrey Claing Université de Montréal, CanadaTitle : Combining Multi-parametric MRI (mpMRI), MR-Ultrasound Fusion Biopsy, and High Intensity Focused Ultrasound (HIFU): A Winning Team in the Fight Against Organ Confined Prostate CancerLes BentzVituro Health, USATitle : Communication network mediated by exosomes as a new therapeutic target for pancreatic cancerSonia A MeloUniversity of Porto,PortugalTitle : Overcoming resistance to TRAIL-induced apoptosis in solid tumor cells by simultaneously targeting death receptors, c-FLIP and IAPsGuanlin WangKunming University of Science and Technology, ChinaTitle : Effects of Clinical Pilates Exercises on Patients Developing Lymphedema after Breast Cancer Treatment
Hulya Ozlem Sener
Fisioterapia Consultancy of Exercise Training, IZMIR - TurkeyTitle : Using “Zero-ischemia” and “Sutureless” Techniques to Implement Laparoscopic Partial Nephrectomy with Holmium LaserQi-Fei WangThe First Affiliated Hospital of Dalian Medical University, CHINA Title : Supportive Care : The Patient's CareLouis CazeCenter Louis Caz, France
Title : Evaluation of early treatment response using dynamic MRI of Drug-Eluting Beads Transarterial Chemoembolization for hepatocellular carcinomaKuniaki AraiKanazawa University Hospital, JapanTitle : FolamiRs: Ligand-targeted, vehicle-free microRNA replacement therapyAndrea KasinskiPurdue University, USATitle : Evaluation of cationic channel TRPV2 as a novel biomarker and therapeutic target in Leukemia-Implications concerning the resolution of pulmonary dysfunctionFouad AziziHamad Medical Corporation (HMC), QatarTitle : A prospective study on chemotherapy induced anaemia in cancer patients undergoing treatment using serisl haemoglobin easurement at the National hospital Abuja, NigeriaSimeon ChineduNational Hospital Abuja, NigeriaTitle : Obesity as a prognostic feature in breast cancerHojouj MohammadDnipropetrovsk medical academy of Health Ministry of Ukraine, UkraineTitle : Oncoloytic Efeebt of newcastle disease virus in treatment of Breast CancerAhmed AlhareryMansoura University, EqyptTitle : Reactive Oxygen Species promote doxorubicin-induced P-gp expression in colon cancer cellsMartha Pinzon-Daza, Universidad del Rosario, ColombiaUniversidad del Rosario, Bogotá-ColombiaTitle : Transition metal complexes/organometallic compounds as anticancer/anti HIV drugs or in pharmaceutical industryPrakash KinthadaJNTU University, India
Speaker Slots AvailableTitle : Protein expression profiling of sorafenib-resistant human renal cancer stem-like cells in three-dimensional in vitro modelZofia Felicja Bielecka Warsaw Medical University, Poland
Title : Membranous Expression of panCD66, CD66 a, CD66 b, and CD66 c and Their Clinical Impact in Acute Leukaemia
Nahla IbrahimCairo University, EgyptTitle : Investigation of LRRC24, a putative negative regulator of ErbB receptor tyrosine kinasesAmber AndrewsHampton University, USATitle : Topology, Trafficking and Membrane Orientation of Cancer-Oocyte Neoantigen SAS1B, an Immunotherapeutic Target in Uterine and Ovarian Tumors Vinuth KoduruUniversity of Virginia, USATitle : Enhancement of Cell Cycle Inhibition Effect of Cetuximab by Using with Stabilized-Silver Solution in Lung Cancer CellsAysun ÖzkanAkdeniz University, Science Faculty, Biology Department, Antalya, TurkeyTitle : Computer-aided detection of breast masses in mammographic imagesOmid Rahmani SeryasatHakim Sabzevari University, Sabzevar, IranTitle : Blocking WNT5A-Interleukin-6-Loop as an Effective Strategy to Impair the Invasive Migration of BRAF-Inhibitor (BRAFi) Resistant Melanoma CellsPurusottam MohapatraSkåne University Hospital, Sweden
cancerscience.conferenceseries.com
cancerscience.conferenceseries.com
Speaker Slots AvailableTitle : Evaluation of Protein Induced by Vitamin K Absence, Macrophage Migration Inhibitory Factor and Golgi Protein 73 versus Alpha Fetoprotein for Hepatocellular Carcinoma Diagnosis and surveillance Nahla IbrahimCairo University, EgyptTitle : Extraction of Breast Cancer Lumps from Mammography Images Using Wavelet Transform and Hidden Markov ModelOmid Rahmani SeryasatHakim Sabzevari University, Sabzevar, IranTitle : Cytotoxic effects of Dichloromethane extract of Basella alba in MCF-7 and MDA-MB-231 breast cancer cellsOmowumi AdewaleUniversity of Ibadan, Ibadan, NigeriaTitle : Nasal cavity tumors in dogs: Minimally invasive electrochemotherapy procedureFelipe MagliettiUniversidad de Buenos Aires, ArgentinaHelena VasconcelosUniversity of Porto, Portugal
***Poster Presentations***Title : New opportunities for use of novel, small-molecule PERK inhibitors Wioletta RozpędekUniversity of Lodz, PolandTitle : Novel strategy to cure cancerAdnan RojeabThe London College, U.KTitle : Transition metal complexes/organometallic compounds as anticancer/anti HIV drugs or in pharmaceutical industryAnne-France LeclercUniversity of Liege and University Hospital Centre of Liege, Liege, BelgiumTitle : Women’s Pursuit in Surpassing Breast CancerSaint Mikhaiella William Jonas Manila Science High School, PhillipinesTitle : Pattern of chemotherapy-related adverse effects among adult cancer patients treated at Gondar university referral hospital, Ethiopia: a cross-sectional studyBegashaw Melaku GebresillassieGondar University, EthiopiaTitle : ExoNet - Intratumor communication network mediated by exosomes in Pancreatic CancerCarolina RuivoInstituto de Investigação e inovação em Saúde, PortugalTitle : Intercellular communication mediated by exosomes as a new therapeutic target for pancreatic cancerNuno Bastos, Instituto de Investigação e inovação em Saúde, PortugalInstituto de Investigação e Inovação da Universidade do Porto, PortugalTitle : Breast Cancer of the Youg Woman : Trends Foreseeable with the level of the area of sidi ben abbes- AlgeriaMessafeur Abdelkrim, University Sidi Bel Abbes - AlgeriaTitle : Assessment of Treatment Compliance and Associated factors among Cervical Cancer Patients in TikurAnbessa specialized hospital, Oncology unit, Ethiopia 2012GebreYitayih AbyuMekelle University, EthiopiaInês SilvaUniversity of Porto, PortugalDiana SousaUniversity of Porto, PortugalJoana PereiraUniversity of Porto, Portugal
Poster Slots Available
NOTE: Program Schedule is subject to change with final allotment of the speaker slots
Contact to Book your Slot ; Mail at [email protected] ; [email protected]
Cancer Science 2017conferenceseries.com
cancerscience.conferenceseries.com
Conference Highlights• Cancer Cell Biology
• Organ Defined Cancers
• Cancer Metastasis
• Cancer Genetics
• Cancer & Tumour Immunology
• Cancer : Genomics & Metabolomics
• Targeted Cancer Therapy
• Stem Cell Therapy
• Cancer Biomarkers
• Cancer Therapy & Treatment
• Alternative Medicine & Cancer
• Cancer Case Reports
• Novel Approaches to Cancer Therapeutics
• Precision Medicine & Cancer Therapy
• Cancer Management & Prevention
• Cancer Pharmacology
For detailed sessions, please visit: http://[email protected]//
Submit your abstract online at: http://[email protected]//abstract-submission.php
Register online: http://[email protected]//registration.php
Cancer Science 2017conferenceseries.com
cancerscience.conferenceseries.com
Glimpses of Cancer Science
Cancer Science 2017conferenceseries.com
cancerscience.conferenceseries.com
Visit the Beautiful City of Lisbon
September 26-28, 2016 London, UK12th World Cancer Conference
Scientific Program
conferenceseries.com
Page 9
RegistrationsConcorde Suite 1&2
Day 1 September 26, 2016
Major Sessions: Cancer | Causes and Prevention | Cancer DiagnosisSession Chair: Alain Charest, Harvard Medical School, USASession Co-Chair: Olivier E Pardo, Imperial College London, UK
Session IntroductionTitle: The tumor supressor INPP4B functions as an oncogenic regulator in a subset of melanomasXu Dong Zhang, University of Newcastle, AustraliaTitle: Plasma thermograms-a new approach for cancer biomarker studiesNichola C Garbett, University of Louisville School of Medicine, USATitle: PDGFRα signaling strength confers sensitivity to vinblastine in glioblastomaAlain Charest, Harvard Medical School, USATitle: p53 protects tumor cell survival via a long non-coding RNA under glucose starvationMian Wu, University of Science & Technology of China, ChinaTitle: NRF2-mediated changes in glutathione metabolism mediate the resistance of EGFR-T790M mutant lung cancer cells to erlotinibOlivier E Pardo, Imperial College London, UK
Panel DiscussionGroup Photo
Lunch BreakMajor Sessions: Cancer Therapy | Cancer Drugs | Stem Cell ResearchSession Chair: Sabine Mai, University of Manitoba, CanadaSession Co-Chair: Shahid Gilani, University Hospital of North Midlands, UK
Session Introduction
Opening Ceremonyconferenceseries.com
Keynote Forum
Introduction
Title: The decline of the prevalence of cancers during organism senescenceAlvaro Macieira-Coelho, French Institute of Health and Medical Research(INSERM), FranceTitle: Early diagnosis of Ovarian carcinoma: Is it possible?Liane Deligdisch, Mount Sinai School of Medicine, USA
Title: Maintrac® CTC detection as a tool to uncover the strategies of tumor cells to evade eliminationKatharina Pachmann, SIMFO GmbH Bayreuth, Germany
Networking and Refreshment Break @ Concorde Foyer
Page 10
Title: A 3D imaging platform to determine the level of genomic instability in cancer Sabine Mai, University of Manitoba, Canada Title: Tumor imaging of small animal by phase contrast X-ray CT techniqueThet Thet Lwin, Kitasato University, JapanTitle: Circulating epithelial cells; ready for Routine?! Stefan Schuster, SIMFO GmbH Bayreuth, GermanyTitle: Severe colitis with docetaxel when used in combination with HER-2 receptor blocking antibodies in breast cancer patientsShahid Gilani, University Hospital of North Midlands, UKTitle: Lymhoepithelioma-like carcinoma of the uterine cervix– association with Epstein-Barr virus and Human papillomavirusAngel Danchev Yordanov, UMHAT Doctor Georgi Stranski-Pleven, BulgariaTitle: A prospective study of dose escalated image guided radiotherapy and concurrent chemotherapy for esophageal cancers: An evolving standard in developing country settingSrinivas Chilukuri, Yashoda Hospitals, India
Networking and Refreshment BreakTitle: Home based carers’ general knowledge of cancer in a rural village of south africaTakalani Grace Tshitangano, University of Venda, South AfricaTitle: Trends in the incidence of oral squamous cell carcinoma: A retrospective studyAmitha J Lewis, Manipal University, India
Panel DiscussionDay 2 September 27, 2016
Concorde Suite 2Keynote Forum
Introduction
Title: The role of stem-like glioma cells in GBM progression and post-treatment recurrenceElla L Kim, Johannes Gutenberg University Medical Centre, GermanyPerineural invasion in pancreatic cancerQingyong Ma, Xi’an Jiaotong University, China
Networking and Refreshment BreakMajor Sessions: Organ Specific Cancers Session Chair: Javier Camacho, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, MexicoSession Co-Chair: Ciro Roberto Rinaldi, University of Lincoln, UK
Session IntroductionTitle: Mechanism of Action of G-quadruplex forming oligonucleotide homologous to the telomere overhang in melanomaNeelu Puri, University of Illinois College of Medicine at Rockford, USATitle: PU.1 Expression correlates with patient disease status in the myelodysplatic syndromes, a new prognostic marker Ciro Roberto Rinaldi, University of Lincoln, UKTitle: The combination astemizole-gefitinib as a novel and promising therapy for human lung cancer: In vitro studiesJavier Camacho, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, MexicoTitle: Near infrared transillumination detection of prostate carcinoma in vitroBesarion Partsvania, Georgian Technical University, GeorgiaTitle: Heightened state of oxidative stress in MCF-7 cells enhances growth potential and promotesEMT by increasing Akt and ERK activityMilad Bitar, Kuwait University, KuwaitTitle: Desmoplasia suppression by Metformin-mediated AMPK activation inhibits pancreatic cancer progressionQingyong Ma, Xi'an Jiaotong University, ChinaTitle: Cytocidal effects of active bufadienolides on human cancer cells and its possibility of enhancing host immunity as an adjuvant therapeutic reagentBo Yuan, Tokyo University of Pharmacy and Life Sciences, Japan
Lunch BreakYoung Researchers Forum
Page 11
Title: Diet and colorectal cancer: Black raspberries prolong lifeStephanie May, Cardiff University, UKTitle: BCG-osis following intravesical BCG treatment leading to miliary pulmonary nodules, penile granulomas & a mycotic aortic aneurysmDavid M Smith, St James’ University Hospital, UK Title: H3K4-specific histone methytranferase MLL3 regulates EMT in pancreatic cancer cellsChenyi Liu, University of Toronto, CanadaTitle: Prodigiosin associated anti metastatic effect and induction of apoptosis in adeno gastric carcinomaN Darshan, Central Food Technological Research Institute, IndiaTitle: frequent v600e & other non-hotspot braf mutations in adult differentiated thyroid cancer Murugan Avaniyapuram Kannan, King Faisal Specialist Hospital & Research Center, KSATitle: Association of proline allele at codon 72 of TP53 gene with triple negative breast cancer (TNBC) in females from North Eastern Region, IndiaKaustab Mukherjee, Regional Medical Research Centre-Dibrugarh, ICMR, India Title: Toxin-based targeted therapeutics for the treatment of solid tumorsStefania Zuppone, San Raffaele Scientific Institute, Italy
Networking and Refreshment BreakPoster Presentations 16:10-18:00 @ Concorde Foyer
Day 3 September 28, 2016Meeting Room 9
Major Sessions: Oncology and Cancer | Cancer Treatment and Therapeutics|Alternative Medicine and Cancer | Radiation OncologySession Chair: Jiri Vachtenheim, Charles University in Prague, Czech Republic
Session IntroductionTitle: GLI2, a Hedgehog signaling pathway effector, is a transcription activator of survivin expression in human tumor cellsJiri Vachtenheim, Charles University in Prague, Czech RepublicTitle: psiTPTE22-HERV functions as a tumor suppressor and is epigenetically down-regulated in gastric cancer Jessie Qiaoyi Liang, The Chinese University of Hong Kong, China
Networking and Refreshment Break 10:40-11:00 @ Concorde FoyerTitle: Pathological diagnosis and workup of lung cancer in the middle east and north africa: patterns and challengesMohammed Al Hajjaj, University of Sharjah, UAETitle: Bamboo shoot consumption lowers the risk of breast cancer: A case-control study from North East Region, IndiaK Rekha Devi, Regional Medical Research Centre-Dibrugarh, ICMR, IndiaTitle: Anaemia in cancer patients undergoing radiotherapy: Our experience at the National Hospital Abuja, NigeriaChinedu S Aruah, National Hospital Abuja, NigeriaTitle: The anti-cancer effect of methanolic extract of Pistacia lentiscus MEPL in human ovarian cancer cellsImane Charid, University Abderrahmane Mira, AlgeriaTitle: Prosopis juliflora lleaves extract induces apoptosis in the breast cancer cells Raju N Gacche, Swami Ramanand Teerth Marathwada University, India
Video Presentation Lunch Break 13:00-13:40 @ Aromi Restaurant
Thanks Giving & Closing Ceremony
Bookmark your dates
e-mail: [email protected]; [email protected]: www.cancer.global-summit.com/europe
19th World Cancer ConferenceOctober 23-25, 2017 Milan, Italy
538th Conferenceconferenceseries.com
10th Global Annual Oncologists MeetingScientific Program
July 11-13, 2016 Cologne, Germany
Conference Series LLC 2360 Corporate Circle, Suite 400 Henderson, NV 89074-7722, USA Ph: +1 702 508 5200 Ext: 8033
e-mail: [email protected]; [email protected]
Page 13
Registrations
Amsterdam
Day 1 July 11, 2016
Networking & Refreshment BreakSession Introduction
Session 1: Oncology & Organ Specific CancerSession Chair: Ajay Singh, Mitchell Cancer Institute, USA Session Co-Chair: Stephanie Notttrott, Isenbruck Bösl Hörschler LLP, GermanyUnderstanding and overcoming chemoresistance of pancreatic cancerAjay Singh, Mitchell Cancer Institute, USAPatent protection for diagnostics and therapeutics - The essentials and importance of second medical use patents in precision medicine Stephanie Notttrott, Isenbruck Bösl Hörschler LLP, GermanyThe chemopreventive potential of silver nanoparticles against UVB-induced skin carcinogenesisSeema Singh, Mitchell Cancer Institute, USAVP: Perioperative use of NSAID might prevent early relapses in breast and other cancers: An upstream approachMichael Retsky, Harvard TH Chan School of Public Health, USA
Group Photo 12:50-13:00Lunch Break
Human borna disease virus infection impacts host proteome and histone lysine acetylation in human oligodendroglia cellsXia Liu, Institute of Forensic Science, ChinaBlockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of gemcitabineYan-Shen Shan, Cheng Kung University, TaiwanEvaluation of actionable mutation (KRAS, BRAF and PIK3CA) in colon cancer: Determination of frequency, distribution pattern in Indian patientsB R Das, Research and Development, SRL Ltd., IndiaChallenges in treating Ca Nasopharynx, Ca Tonsil and post op Head neck cancers by Intensity Modulated RadiationtherapyAnitha Gopal, Fortis hospitals, India One-step mixing with anti-tumor/anti-CD3 bispecific antibody enhances tumor targeting and therapeutic efficacy of ex vivo expanded T cellsKuo-Hsiang Chuang, Taipei Medical University, Taiwan
Networking & Refreshment BreakDendritic cell vaccine therapy in breast cancer patientsYathish Kumar, Karnataka cancer hopsital & research centre, IndiaRevisiting the value and role of anti-angiogenesis in solid tumors and the mechanism to inhibit angiogenesis, and their possible complications: Pediatric oncologists view. Mahdi Shahriari, Shiraz University of Medical Sciences, IranAbsence of the FANCM c.5101C>T mutation in BRCA1/2-negative triple-negative breast cancer patients from Pakistan Muhammad U Rashid, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Pakistan
Opening Ceremonyconferenceseries.com
Keynote ForumIntroduction
Sensitivity and specificity of the empirical Lymphocyte Genome Sensitivity (LGS) assay: Implications for improving cancer diagnostics Diana Anderson, University of Bradford, UKOptimizing HER2 assessment in breast cancer - Application of automated image analysisMartin Kristensson, Visiopharm, Denmark
Page 14
Day 2 July 12, 2016Amsterdam
Keynote ForumIntroduction
Isolated Thoracic Perfusion with Chemofiltration (ITP-F) breaks through drug resistance in progressive and pretreated malignant pleural mesotheliomaKarl R Aigner, Medias Klinikum GmbH & Co KG, GermanyNew method of quantitative, circulating tumor cell (CTC) diagnostic, treatment selection, monitoring and surveillance with superior outcome for the patientMatin Burrow, DMB-Diagnostics GmbH, Germany
Networking & Refreshment BreakSession 2: Cancer Causes, Cancer Diagnostics, Cancer Treatment and Therapy & Clinical Oncology
Session IntroductionSession Chair: Diana Anderson, University of Bradford, UKSession Co-Chair: Apollon Karseladze, N. Blokhin Cancer Research Center, Russian FederationGeneral overview of the Comet assayDiana Anderson, University of Bradford, UKThe march of pathologists into ‘Big Industry’ or the worries of a newly transformed surgical pathologistDiana Stanoeva, Histogenex, BelgiumImpairment of vascularization of the surface covering epithelium induces ischemia and promotes malignization: A new hypothesis of a possible mechanism of cancer pathogenesisApollon Karseladze, N. Blokhin Cancer Research Center, Russian FederationCholesterol Import and steroidogenesis are Biosignatures for gastric cancer progressionWen-Lung Ma, China Medical University Hospital, Taiwan
Lunch BreakPoster Presentation
Z-BeEAM (Ibritumomab tiuxetan, Bendamustine, Etoposide, Cytarabine, Melphalan) before autologous stem cell transplantation is safe and efficient for refractory large B-cell lymphoma Magalie Tardy, Centre Antoine Lacassagne, FranceThe fetal risks from diagnostic use of radiation during pregnancy: A systematic review and proposal of a clinical protocol Mafalda Sofia Barros Gomes, Centro Hospitalar do Porto, PortugalPrognostic factors and their correlation with staging in patients with Multiple Myeloma: A single centre study in North IndiaTanvi Sood, Shri Ram Murti Smarak Institute of Medical Sciences, IndiaVP: MicroRNA-21 expression in primary breast cancer tissue among female patients and its correlation with chromosome 17 aneusomy Noura Ramadan, Suez Canal University, EgyptCombined bevacizumab and stereotactic radiosurgery for the treatment of a child with recurrent medulloblastomaMing Zhao, Chinese PLA General Hospital, China
Keynote ForumKeynote Presenation by Hirendra Nath BanerjeeElizabeth City State University, USA
Networking & Refreshment BreakAward Ceremony
Day 3 July 13, 2016 Extended Networking Session & Lunch
e-mail: [email protected] web: annualmeeting.conferenceseries.com/oncologists/
Bookmark your dates
April 24-25, 2017 Dubai, UAE16th Global Annual Oncologists Meeting
Conference Series LLC2360 Corporate Circle, Suite 400Henderson, NV 89074-7722, USA
Ph: +1-888-843-8169Fax: +1-650-618-1417
Conference Series LtdHeathrow Stockley Park Lakeside
House, 1 Furzeground WayHeathrow, UB11 1BD
United [email protected]
OMICS International6th Floor, North Block
Divyasree Building, Raidurg Hyderabad Telangana, INDIA-500032
Tel: [email protected]
Toll freeUSA & Canada: +1-800-216-6499
Australia: +1-800-651-097Europe: 0805-080048
Page 15
June 13-15, 2016 Rome, ItalyCancer Diagnostics Conference & Expo
Scientific Programconferenceseries.com
Hosting Organization: Conference Series LLC 2360 Corporate Circle, Suite 400 Henderson, NV 89074-7722, USA Ph: +1-702-508-5200 Ext: 8047, Toll free: +1-800-216-6499
e-mail: [email protected]; [email protected]
Page 16
Registrations
Opening Ceremony
Day 1 June 13, 2016
Group PhotoNetworking & Refreshments Break
Track 1: Cancer Diagnostics MarketTrack 2: Cancer Diagnostics Types
Session IntroductionSession Chair: Diana Anderson, University of Bradford, UKSession Co-Chair: Tibor Tot, Central Hospital Falun, Sweden Title: Fast Evaluation of Biopsy for Prostate Cancer Diagnosis by Fraunhofer IKTSAndreas Lehmann, Fraunhofer Institute for Ceramic Technologies and Systems IKTS, GermanyTitle: How to develop a cancer diagnostic device for the POC settingJuan Roman, Cambridge Consultants, UKTitle: Engineering design process and comparison of multi wavelength real time auto-fluorescence and fluorescence imaging guide system irradiance with xenon lamps and light-emitting diodes (LEDs) for open and laparoscopic cancer surgeryHyun Soo lim, Chungnam National University, South KoreaTitle: Development of female vaginal fluid collection device for the endometrial cancer preliminary studyJhih-Yan Cheng, National Tsing Hua University, Taiwan
Lunch BreakTrack 7: Predictive Cancer Biomarkers Track 9: Cancer Treatment
Session IntroductionSession Chair: Diana Anderson, University of Bradford, UKSession Co-Chair: Tibor Tot, Central Hospital Falun, Sweden Title: The role of pancreatic stellate cells in pancreatic disordersOleg V Gerasimenko, Cardiff University, UKTitle: Differences of signalling pathways and miRNA expression in colon and breast carcinoma cell lines on hipoxic conditionHafize Seda Vatansever, Celal Bayar University, TurkeyTitle: The role of Epo/EpoR signaling pathway in colorectal cancerRenata Dobrila Dintinjana, Clinical Hospital Center Rijeka, CroatiaTitle:Fertility sparing surgery in early stages of cervical cancer Aleksandar Stefanović, President M.D. Ph. D UGOSCGRS, BelgradeTitle: Fertility sparing in young patients with early stages of endometrial cancer Katarina Jeremic, University of Belgrade School of Medicine, Serbia
Networking & Refreshments Break
Olimpica-4
conferenceseries.com
Keynote Forum
Scientific Program
Introduction
Title: Sensitivity and Specificity of the Empirical Lymphocyte Genome Sensitivity (LGS) Assay: Implications for Improving Cancer DiagnosticsDiana Anderson, University of Bradford, UKTitle: Optimal Breast Cancer Pathology 2016Tibor Tot, Centarl Hospital Falun, Sweden
Page 17
Title: Anticancer activities of religiously important plants from IndiaRachana, Jaypee Institue of Information Technology, IndiaTitle: Prostatic tissue levels of chemical elements as cancer markersVladimir Zaichick, Medical Radiological Research Center, Russia
Special SessionTitle: Breast Cancer HeterogenityTibor Tot, Central Hospital Falun, Sweden Title: General Overview of the Comet assayDiana Anderson, University of Bradford, UK
Day 2 June 14, 2016Olimpica-4
Keynote Talk
Title: The UHRF1 expression in serum and tissue for gastric cancer detectionFeng Yan, Nanjing Medical University and Jiangsu Cancer Hospital, China
Track 3: Cancer Screening TestsTrack 6: Approaches in Cancer TherapyTrack 8: Cancer Genomics and EpigeneticsTrack 10: Recent Diagnostics Technologies
Session IntroductionSession Chair: Feng yan, Nanjing Medical University and Jiangsu Cancer Hospital, ChinaSession Co-Chair: Senqing Chen, Nanjing Medical University and Jiangsu Cancer Hospital, ChinaTitle: Serum biomarkers and ovarian cancer risk: Utility for early detection and preventionDayan Goodenowe, President, Phenomenome Discoveries Inc., CanadaTitle: Molecular basis of hereditary colorectal cancer and current research statusChen Senqing, Jiangsu Institute of Cancer Research, China
Networking & Refreshments BreakTitle: The mechanisms of asparaginase-induced pancreatitisJulia V Gerasimenko, Cardiff University, UKTitle: Tumor-derived exosomes in cancer progression and treatment failureShaorong Yu, Jiangsu Institute of Cancer Research, ChinaTitle: Mast cells inhibition as therapeutic approach on mammary cancerAna I Faustino-Rocha, University of Trás-os-Montes and Alto Douro, Portugal
Poster PresentationsCDE001 Title: Prognostic significance of N-glycolyl GM3 ganglioside expression in non-small cell
lung carcinoma patients: New evidencesAdriana Carr Perez, Center of Molecular Immunology, Cuba
CDE002 Title: A functional approach for searching biomarkers of gliomaKopylov Alexey, Lomonosov Moscow State University, Russia
CDE003 Title: Molecular study of synthesis of protoporphyrin IX in fluoropositive and fluoronegative cell cultures of human glioblastomaPavlova Galina, Institute of Gene Biology-RAS, Russia
CDE004 Title: Renal cell carcinoma in kidney transplant candidatesKonstantinos A Zorbas, Temple University Hospital, USA
CDE005 Title: Frequent ID4 gene promoter hypermethylation in breast cancerYan Zhang, Jiangsu Cancer Hospital, China
CDE006 Title: Asymmetrical asymptomatic tonsilsJoseph Colclough, Northwick Park Hospital, UK
CDE007 Title: New ruthenium phthalocyanines in modulation of nitric oxide and singlet oxygen release: Physical chemical characterizations and improvement of cytotoxicity with liposomes against cancer cellsRamos L.C.B, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Brazil
CDE008 Title: The role of FABP9 in prostate cancerMajed Al Fayi, Liverpool University, UK
CDE009 Title: Experimental treatment of prostate cancer by suppressing the biological activity of FABP5Waseem Al-Jameel, University of Liverpool, UK
CDE010 Title: Improving Breast Cancer diagnosis by circulating microRNAs Julia Alejandra Pezuk, Instituto Sirio-Libanes de Ensino e Pesquisa – Hospital Sirio-Libanes- Sao Pablo, Brazil
Lunch Break
Page 18
Title: Comparison of the MRI sequences in ideal fiducial marker-based radiotherapy for prostate cancerOsamu Tanaka, Gifu Municipal Hospital, JapanTitle: Monitoring cancer progression by detecting circulating cancer cells with both epithelial and mesenchymal featuresYong-Jie Lu, Queen Mary University of London, London, UKTitle: The status of medicinal plants and herbal drugs in prevention and treatment of cancerMajid Asadi-Samani, Shahrekord University of Medical Sciences, IranTitle: Probable non-papillomavirus etiology of warty carcinoma of the uterine cervixDimitrova B, Medical University Pleven, BulgariaTitle: The possible involvement of Epstein–Barr virus in the etiology of leukemia in Sudanese patientsHaitham Eltigani Mohammed Elawad, Omdurman Islamic University, Sudan
Networking & Refreshments BreakTitle: Combination Therapy against NGcGM3 ganglioside and EGFR: A new approach for lung cancer treatment.Adriana Carr Perez, Center of Molecular Immunology,CubaTitle: Evaluation of the SYT-SSX2 fusion gene transcript in synovial sarcoma cells and microvesicles as a potential biomarker for synovial sarcomaFricke Alba, University of Freiburg, Germany
Panel DiscussionsAward & Closing Ceremony
Day 3 June 15, 2016Networking and Lunch @ 12.00-13:00 @ Restaurant
E-mail: [email protected]: cancerdiagnostics.conferenceseries.com/
Bookmark your dates
2nd Cancer Diagnostics Conference and ExpoMay 08-10, 2017 Dubai, UAE
Conference Series2360 Corporate Circle, Suite 400Henderson, NV 89074-7722, USA
Ph: +1-888-843-8169Fax: +1-650-618-1417
Conference Series5716 Corsa Ave., Suite 110, Westlake
Los Angeles, CA 91362-7354, USAPh: +1-650-268-9744Fax: +1-650-618-1414
Conference SeriesSEZ Unit, Building No. 20, 9th Floor
APIIC Layout, HiTec CityHyderabad-500081, Telangana, INDIA
Ph: 040-40131823, [email protected]
Toll freeUSA & Canada: +1-800-216-6499
Australia: +1-800-651-097Europe: 0805-080048
Scientific Program389th OMICS International Conference
OMICS International Conferences2360 Corporate Circle., Suite 400 Henderson, NV 89074-7722, USA
Phone: +1-888-843-8169, Fax: +1-650-618-1417, Toll free: +1-800-216-6499Toll free: +1-800-216-6499, Email: [email protected]
Cancer TherapySeptember 28-30, 2015
Atlanta, USA
5th World Congress on
canc
ersu
mm
it.or
g
Exhibitor
Page 20
Scientific Sessions:Cancer Cell Biology, Diagnosis & Applied ResearchOrgan-Specific CancerAdvances in Malignancy Counteractive Action and Screening
Session Chair: Yoshiaki Omura, New York Medical College, USASession Chair: Fereydoon Family, Emory University, USA
Session IntroductionNon- Invasive, quick, simple diagnostic method and safe, effective, individualized treatment of various cancers without side effectsYoshiaki Omura, New York Medical College, USAIdentification of Quinones as growth inhibitors of Trastuzumab resistant breast cancer cellsJayalakshmi Sridhar, Xavier University of Louisiana, USAHigher grade Gliomas have more diffused invasive fronts: Quantitative histology analysis of IDH1+ GliomasFereydoon Family, Emory University, USAExosomes in the treatment of pancreatic adenocarcinomaHoracio Rilo, North Shore LIJ Health Systems, Hofstra University, USAHepatocellular carcinoma screening in Cirrhosis: Inappropriate use of CT / MRI scanAshwani K. Singal, University of Alabama, USA
Group Photo Lunch Break
RegistrationsDay 1 September 28, 2015
Chattahoochee Salon C
Scientific Program
Opening CeremonyKeynote Forum
IntroductionA review of cancer immunotherapies and nutritional therapiesJack C. Westman, University of Wisconsin School of Medicine & Public Health, USA
BAI1 is a brain-specific tumor suppressorErwin G. Van Meir, Winship Cancer Institute, Emory University, USANew simple method of detecting various cancers & their biochemical information from rapidly changing part of QRS complex of ECGs and its clinical application for screening and evaluation of cancerYoshiaki Omura, New York Medical College, USA
Systemic and interstitial photodynamic laser therapy: New options in oncologyMichael Weber, Weber Medical, Germany
Coffee Break
Chemoprevention of experimental mammary carcinoma by Trianthe ma portulacastrum Linn., an Indian dietary and medicinal plantAnupam Bishayee, Larkin Health Sciences Institute College of Pharmacy, USA
Page 21
Atypical PKC signaling and breast cancer metastasisSoumen Paul, University of Kansas Medical Center, USAAnti-Cancer preparation NSC 631570Wassil Nowicky, Ukrainian Anti-Cancer Institute, AustriaTarget genes for acidosis-dependent anti-cancer drugsHiroshi Kobayashi, Chiba University, JapanControlling Ras stability via the Wnt/β-catein signaling: Implication in cancer therapyKang-Yell Choi, Yonsei University, KoreaBaicalein increases the expression and reciprocal interplay of RUNX3 and FOXO3a through crosstalk of AMPKa and ERK1/2 signaling pathways in human non-small cell lung cancer cellsSwei Sunny Hann, University of Guangzhou Traditional Chinese Medicine, ChinaRelB-mediated EMT activation promotesbone metastasis of prostate cancerYong Xu, Nanjing Medical University, ChinaHypermethylation of P15, P16, and E-cadherin genes in ovarian cancerTaha A. Kumosani, King Abdulaziz University, Saudi ArabiaUV light analisys of anticancer drug NSC 631570 in urine samples sorts healthy donors and prostate adenocarcinoma patients. Could the different drug up-take used to establish free-diagnosis cancer patients?Larysa M. Skivka, ESC “Institute of Biology”, Taras Shevchenko National University, Ukraine
Coffee Break
The relevance of the cytological diagnostic in the mamary gland cancerCiobica Alin, Alexandru Ioan Cuza University, RomaniaEffect of dietary fatty acids on development of carcinogen-induced breast cancer in female fisher (F344) ratsSurekha MV, National Institute of Nutrition, IndiaSprague Dawley/NIN hairless mutant rat–A model to study carcinogenesis? M. SatyaVani, National Institute of Nutrition, IndiaChemopreventive effects of gingerNirmala Kota, National Institute of Nutrition, IndiaSesame lignans: Potent components as nutraceuticals/functional foodsHemalatha Sanagaram, National Institute of Nutrition, IndiaClinical characterization of patients with diagnosis of lung cancer in Joaquin Albarran´s Teaching HospitalJoan Fabian Fernandez de la Vega, General Calixto Garcia´s Teaching Hospital, CubaThe EGFR- targeted chimeric antigen receptor- modified T cells immunotherapy for patients with EGFR- expressing advanced or relapsed/refractory solid tumorsWeidong Han, The General Hospital of PLA, ChinaContext specific role of deubiquitylase enzyme, USP9X in oral squamous cell carcinomaDevathri Nanayakkara, Griffith University, Australia
Day 2 September 29, 2015
Chattahoochee Salon C
Scientific Sessions:Anti Cancer Drugs & DeliveryNovel Approaches to Cancer TherapeuticsCancer Therapy Clinical Cancer ResearchCancer & Lifestyle ConnectionComplementary & Alternative Medicine (CAM)Cancer BiomarkersCancer Nanotechnology
Session Chairs: Yoshiaki Omura, New York Medical College, USASherri Z. Millis, Advanced Individual Medicine, USA
Session Introduction
Page 22
Molecular engineering of Fc fusion proteins to tailor effector function to clinical indicationSteven Chamow, Chamow & Associates Inc., USACancer cell- state plasticity and resistance to therapyRaffaella Sordella, Cold Spring Harbor Laboratory, USADevelopment of protein agent targeting Integrins αvβ3 at a novel site by rational protein designZhi-Ren Liu, Georgia State University, USAHyaluronic Acid (HA) drug conjugates for targeted delivery of anticancer drugs: CA102N, A novel Hyaluronic acid conjugated drug against colorectal cancerEskouhie Tchaparian, Holy Stone Healthcare Co., Ltd., TaiwanDifferent uptake of Ukrain can explain the selective effect against pancreatic adenocarcinoma cell cultures in vitroNiccola Funel, University of Pisa, ItalyA persulfide analog of the nitrosothiol SNAP, D-P*, induces apoptotic cell death in Jurkat leukemia T-cellsBurkhard Kloesch, Ludwig Boltzmann Institute for Rheumatology, Austria
Coffee Break
Alkoxyamines for the in-situ generation of radicals as theranostic agentsPaul Bremond, Aix-Marseille University, FranceTyrosine Isomers mediate the classical phenomenon of concomitant tumor resistance and exhibit a powerful anti-metastatic effect with undetectable toxic-side effects Raul A. Ruggiero, National Academy of Medicine, IMEX-CONICET, ArgentinaSynthesis and preliminary mechanistic evaluation of N-(Substituted-1,3-Benzothiazol-2-yl)-2-(4-Substituted-Piperazin-1-yl) Acetamide derivatives with potent antiproliferative activity on human cancer cell linesMine Yarim, Yeditepe University, TurkeyAnti-tumor activity of Wei-Shen: Pre- Clinical and clinical studiesYuguo Yu, Jiangsu Andeson Biomedical Inc., ChinaGold nanorods-incorporated mesoporous magnetic nanoparticles for targeted drug delivery and near-infrared photothermal therapy in cancerHung-Wei Yang, National Sun Yat-sen University, TaiwanAssessment of the stemness-suppressive effects of several SHP-1 activators in human colorectal cancer cellsYeu Su, National Yang-Ming University, TaiwanModulated electro-hyperthermia: A local treatment may evoke distant anti-tumor response in a mice double colorectal allograft modelTamas Vancsik, Semmelweis University, Hungary
Lunch Break
Profiling cancer gene mutations in non-small cell lung cancer by droplet digital PCRDongqi Tang, The Second Hospital of Shandong University, ChinaAssessment and treatment of cancer pain: Our experience in SerbiaGvozdenovic Ljiljana, Clinical Center of Vojvodina, SerbiaNanotubes and their functions in cancerH. Seda Vatansever, Celal Bayar University, TurkeyImplications for antimicrobial, anticancer activity and molecular docking studies of N4-Tetradentate Tin macrocyclesEkta Rawat, Kurukshetra University, IndiaDevelopment and preclinical testing of protein-based curcumin delivery forms for control of cancerLissy Krishnan, Sree Chitra Tirunal Institute for Medical Sciences and Technology, IndiaBioengineered Fusokine GIFT4 for cancer immunotherapyJiusheng Deng, Emory University School of Medicine, USAMonoclonal antibodies that target pancreatic and colorectal cancer for both diagnosis and therapyMyron Arlen, North Shore University Hospital, USA
Coffee Break
Page 23
13C and 1H NMR metabolic markers of therapeutic response upon signal transduction inhibitors in lymphoma cells and in vivoSeung-Cheol Lee, University of Pennsylvania, USANext generation sequencing methodologies in identifying biomarkers and treatment options across cancersSherri Z. Millis, Advanced Individual Medicine, USAThe effects of animal- assisted interventions (AAIs) for pediatric oncology patients and their parents at five hospital sitesAmy McCullough, American Humane Association, USAAlterations in actin binding proteins and miR~17-92 cluster in cancer cell metastasis and attenuation by DHAMehboob Ali, The Research Institute at Nationwide Children’s Hospital, USACytoreductive surgery and HIPEC for peritoneal carcinomatosis of a gallbladder carcinomaElke Wagler, Department of General, Visceral and Oncosurgery, Pleißental-Klink Werdau, GermanySupporting the survivors: Cancer fatigue syndome and cancer rehabilitationNaomi Dolgoy, University of Alberta, CanadaCombining ultrasound and nanoparticle for cancer treatmentChung-Hsuan (Winston) Chen, Genomics Research Center, Academia Sinica, Taiwan
Day 3 September 30, 2015
Chattahoochee Salon CScientific Sessions:Cancer ChemotherapyPediatric OncologyAnti-Cancer Agents in Medicinal ChemistrySession Chairs: Michael Weber, Weber Medical, GermanyDeniz Peker, University of Alabama, USA
Session IntroductionA unique case of synchronous extramedullary spinal masses-is surgery an answer?Rachana Yendala, University of Toledo Medical Centre, USAFeasibility assessment foroncology trialsMaxim Belotserkovskiy, Global Head Medical Affairs at PSI CRO AG, SwitzerlandIdentifying the border of cutaneous squamous cell carcinoma by targeted EGFR antibodies conjugated to gold nanoparticlesAsaf Olshinka, Rabin Medical Center, IsraelThe presence of aflatoxin B1-FAPY adduct and Human Papilloma Virus in cervical smears from cancer patients in MexicoMagda Carvajal, National Autonomous University of Mexico, Ciudad Universitaria, MexicoCytotoxyc effect of Solanum rastratum dunal (mexican thisle) on cervical cancer cells (Siha)Maria Del Carmen Valadez Vega, Instituto de Ciencias de la Salud, MexicoPolymorphisms in one- carbon metabolism pathway affect survival of Chinese resected gastric cancer patientsJinfei Chen, Nanjing First Hospital, China
Coffee BreakAnalysis of APOBEC3 and driver genes polymorphisms in Moroccan patients with breast cancerChaymaa Marouf, University Hassan II Ain Chock, MoroccoEstimating the total cost of cancer management: A descriptive prospective Cohort study among patients with cervical cancer at Ocean Road Cancer Institute, Dar es Salaam, TanzaniaHarrison R. Chuwa, Ocean Road Cancer Institute (ORCI), TanzaniaFirst inhibitors of the human mitotic Kinesin MKLP-2 synthesis, biological evaluation and structure-activity relationshipsCatherine Guillou, Gif Research Center, CNRS, LabEx, FranceRecognizing paediatric brain tumours in the emergency departmentBabakhanlou R, University of Edinburgh, ScotlandDesign, synthesis and antiproliferative activity of 6-substituted Pyridazin- 3(2H)-onesMohamed Elagawany, Damanhour University, EgyptCancer therapy, a review on anti neoplastic agentJuhi Tiwari, Jayoti Vidyapeeth Women’s University, IndiaSecondary malignancies as long term adverse effects of chemo- and radiation therapyDeniz Peker, University of Alabama, USA
Lunch BreakWorkshop on
Page 24
The practical applications of lasers for photodynamic cancer therapyMichael Weber, Weber Medical, GermanyThe Frequency of nucleophosmin1 gene mutation in newly diagnosed patients of acute myeloid leukaemiaMuhammad Ayyub, Armed Forces Institute of Pathology, PakistanAssociation between GSTP1 genotypes and hormone receptors phenotype in invasive ductal carcinomas of breastMarwan A. Bakarman, King Abdulaziz University, Saudi ArabiaResveratrol gold nanoparticles: Synthesis, characterization and in-vitro anticancer activityShrinivas Bumrela, Sinhgad Institute of Pharmaceutical Sciences, IndiaToxicological evaluation of anticancer α- Eleostearic acid rich fat extracted from seeds of bittermelon (Momordicacharantia) using a mouse modelK.N.K. Ranasinghe, University of Peradeniya, Sri LankaFirst-in-class GnRH analog for cancer therapyGregory Lee, University of British Columbia, Canada
Coffee BreakInhibition of multidrug resistance protein I (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiformeTivnan A., Royal College of Surgeons in Ireland, IrelandSUMOylation: A link to future therapeuticsFaheem Ahmed Khan, Huazhong Agricultural University, ChinaS.I.M.P.L.E.™ permanent hair removal as an option for unwanted hair growth experienced asa side-effect of cancer treatment drugsSuzanne Anderer, Illinois School of Electrology, USAFertility of female lymphoma patients treated with chemotherapyHelen Gharwan, Sinai Hospital of Baltimore, USATRB2-SKP2 signaling and SKP2 targeted therapy in human retinoblastoma and related tumorsXiaoliang X. Xu, Zhongshan University, ChinaMesenchymal stem cells as carriers and amplifiers in CRAd delivery to tumorsXia Xi, Peking University Shenzhen Hospital, China
Award Ceremony
Poster Session
CTPO01Prevalence of cell-free DNA mutations in patients with renal cell carcinoma: Preliminary findingsChristopher Keith, Emory University School of Medicine, USA
CTPO02Bacterial MazF mediated apoptosis in colorectal adenocarcinoma HT29 cellsMaryam Saffarian, Clemson University, USA
CTPO03G-quadruplex formation in the kRAS mid promoter region and identification of stabilizing small molecules as promising transcriptional silencersRhianna K Morgan, University of Mississippi, USA
CTPO04Potentiating of human papilloma vaccine candidate using Naloxone/Alum mixture as adjuvant: Increase of the immunogenicity and polarization to Th-17Mahsa Yasaghi, Islamic Azad University of Pharmaceutical Science, Iran
CTPO05Adherence to postmastectomy radiation therapyamong N2/N3 female breast cancer in Taiwan and its associated predicting factors: a national wide retrospective population-based studyZhen-Ying Liu, Koo Foundation Sun Yat-Sen Cancer Center, Taiwan
CTPO06Synthesis of functional liposomes for targeted chemotherapy and photodynamic therapy in brain tumorChih-Wen Lin, National Tsing Hua University, Taiwan
CTPO07Mesoporous nanoparticles-incorporated temperature-sensitive hydrogel for controlled drug/gene delivery in brain tumorFeng-Wei Lin, National Sun Yat-sen University, Taiwan
CTPO08Hypodermic drug delivery for androgen inhibition using dissolving microneedle patches in prostate cancer therapyJing-Fong Liao, National Sun Yat-sen University, Taiwan
CTPO09Immunomodulatory molecules in glioblastoma multiforme tissues and primary cellsShao-Chih Chiu, China Medical University, Taiwan
Page 25
CTPO10Status of GSTP1 homozygous variant allele (Val/Val) genotype and susceptibility to colorectal cancer in Saudi ArabiaMarwan A. Bakarman, King Abdulaziz University, K. Saudi Arabia
CTPO11Pharmaco-dynamic of peptide HM-3 and its effect on HCT-116 tumor micro-environment SitelbanatSitelbanat Yassin, China Pharmaceutical University, China
e-posters
e-CTPO01What kinase gene expressed differently in primary and metastatic kidney cancerAmy Zhao, University of Alabama, USA
e-CTPO02Morphofunctional inactivation of Jurkat T-cells by the titanium oxides coatingKhlusov I A, Siberian State Medical University, Russia
e-CTPO03Synthesis and apoptotic potential establishment of 1,2-oxaphospholesDobromir D Enchev, Konstantin PreslavskyUniversity, Bulgaria
e-CTPO04Molecular interaction studies of Anthraquinone derivatives, potent anticancer agents from the root of Morinda Citrifolia (Noni)Shine. D., D. Y. Patil University, India
e-CTPO05The relevance of some molecular markers in recurrent pancreatic cancer: Focusing on CA 19-9 and cytokeratinsAlin Ciobica, Alexandru Ioan Cuza University, Romania
e-CTPO06The importance of clinical and instrumental diagnostic in the mamary gland cancerAlin Ciobica, Alexandru Ioan Cuza University, Romania
e-CTPO07Studying the post-operatory and molecular modifications in the chronic pancreatitis and pancreatic cancer: Micronutrients and pancreatic enzyme supplementationAlin Ciobica, Alexandru Ioan Cuza University, Romania
e-CTPO08A study regarding the quality of life evaluation in patients with terminal pancreatic cancerAlin Ciobica, Alexandru Ioan Cuza University, Romania
e-CTPO09Psychological and psychiatric manifestations in patients with cancerAlin Ciobica, Alexandru Ioan Cuza University, Romania
e-CTPO010Understanding tumoral markers in patients with pancreatic cancerAlin Ciobica, Alexandru Ioan Cuza University, Romania
e-CTPO011Working with paradoxes: Moving from dialectical opposition to interdependent growth in culturally diverse female cancer survivorsKirti Patel, Sofia University, USA
Closing Ceremony
OMICS International2360 Corporate Circle, Suite 400Henderson, NV 89074-7722, USA
Ph: +1-888-843-8169Fax: +1-650-618-1417
OMICS International5716 Corsa Ave., Suite 110, Westlake
Los Angeles, CA 91362-7354, USAPh: +1-650-268-9744Fax: +1-650-618-1414
OMICS GroupSEZ Unit, Building No. 20, 9th Floor
APIIC Layout, HITEC CityHyderabad-500081, Telangana, INDIA
Ph: 040-40131823, [email protected]
Toll freeUSA & Canada: +1-800-216-6499
Australia: +1-800-651-097Europe: 0805-080048
Bookmark your dates14th World Congress on
December 08-10, 2016 Baltimore, USACancer Therapy
